FRIDAY, June 11, 2021 (HealthDay News) — U.S. regulators have extended the expiry date on countless Johnson & Johnson coronavirus vaccine doses by 6 weeks, the business announced Thursday.
A U.S. Food and Drug Administration review reasoned the shots stay safe and effective for at least 4 1/2 months, J&J stated in a statement. In February, the FDA first approved the embryo for up to three months when stored at normal refrigeration temperatures.
State officials had warned earlier this week that many J&J doses in storage could perish prior to the close of the month. The FDA change provides health companies more time to use shots sitting at hospitals hospitals and clinics, the Associated Press reported. Many states have adopted a”first-in-first-out” strategy to try and use their earliest vaccines first.
Vaccine expiration dates are based on data from drugmakers on how long the shots stay viable. J&J explained the FDA additional six months based on information in the company’s continuing studies on the vaccine’s stability.
The FDA has been reviewing expiration dates on all 3 vaccines authorized in this nation as companies have continued to examine batches from the months since the shots first rolled out. Vaccines in Pfizer and Moderna, approved in December, have a six-month shelf life, the AP reported.
Unfortunately, vaccination rates have been dropping recently: The country averaged about 800,000 new shots daily last week. That is down from a high of almost 2 million daily shots two months past, the AP reported. Government officials and companies have switched to incentives to promote shots, such as paid time off and $1 million awards.
As vaccinations have slowed, Biden’s aim of having 70% of adults partly vaccinated from July 4 is in peril. As of Friday, approximately 64% of Americans over 18 have had at least one shooter, according to the U.S. Centers for Disease Control and Prevention.
J&J’s vaccine was highly anticipated because of its one-and-done formula and easy-to-ship refrigeration. The shot has been expected to play a key role in vaccination campaigns in rural locations along with low carb countries with limited health care, the AP reported.
But rival drugmakers Pfizer and Moderna have already supplied more than sufficient doses to fulfill U.S. demand. More than 129 million Americans have been completely vaccinated with all the firms’ two-dose shots, the AP reported. Meanwhile, just 11 million Americans have been vaccinated with the J&J shot. About 10 million more J&J doses have been sent out to states, according to the CDC.
Use of J&J’s vaccine appears to have also been hurt by links to a rare blood clot disorder. That issue prompted U.S. health officials to “pause” use of the shot for an 11 days. That hold was lifted in late April after officials concluded the vaccine’s benefits outweighed its risks.
G-7 joins US in pledge to send vaccine doses to countries in need
The leaders of the G-7, the world’s richest democracies, are expected on Friday to promise they will send 1 billion doses of COVID vaccines to poor and middle-income countries as part of a campaign to”vaccinate the world” by the end of 2022.
President Joe Biden announced on Thursday that the United States plans to purchase 500 million doses of Pfizer’s coronavirus vaccine that it will then donate to countries in need around the world. As for the rest of the G-7, the U.K. will donate 100 million doses, while other members of the G-7 will contribute the rest, the AP reported.
“This is all about our responsibility, our humanitarian obligation, to save as many lives as we could,” Biden sai